Company page

Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc. (Ticker: LRMR) is a public company based in the United States, focusing on developing innovative therapies for rare diseases. With a market capitalization of approximately $360.5 million, Larimar is dedicated to advancing its research and development efforts in the biopharmaceutical sector. The company aims to address unmet medical needs through its specialized treatment solutions.